Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.28 USD | +7.30% | +13.93% | +65.28% |
04-30 | Transcript : Silk Road Medical, Inc, Q1 2024 Earnings Call, Apr 30, 2024 | |
04-30 | Earnings Flash (SILK) SILK ROAD MEDICAL Reports Q1 Revenue $48.5M, vs. Street Est of $44.7M | MT |
Evolution of the average Target Price on Silk Road Medical, Inc
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Silk Road Medical, Inc
Argus | |
Piper Sandler | |
Stifel Nicolaus | |
Lake Street | |
Oppenheimer | |
Wolfe Research | |
BofA Securities | |
B. Riley | |
Citigroup | |
Nephron Research | |
CL King | |
JPMorgan Chase | |
SVB Leerink |
EPS Revisions
- Stock Market
- Equities
- SILK Stock
- Consensus Silk Road Medical, Inc